Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme
Authors
Challapalli, A.Watkins, S.
Cogill, G.
Stewart, G.
Ellis, S.
Sykes, A.
Nobes, J.
Yip, K.
Barthakur, U.
Board, R.
Gadve, A.
O'Toole, L.
Kent, C.
Mackenzie, J.
Papa, S.
Fusi, A.
Fife, K.
Issue Date
2022
Metadata
Show full item recordCitation
Challapalli A, Watkins S, Cogill G, Stewart G, Ellis S, Sykes A, et al. Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme. J Eur Acad Dermatol Venereol. 2022.Journal
Journal of the European Academy of Dermatology and VenereologyDOI
10.1111/jdv.18082PubMed ID
35298050Additional Links
https://dx.doi.org/10.1111/jdv.18082Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1111/jdv.18082
Scopus Count
Collections
Related articles
- Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
- Authors: Migden MR, Khushalani NI, Chang ALS, Lewis KD, Schmults CD, Hernandez-Aya L, Meier F, Schadendorf D, Guminski A, Hauschild A, Wong DJ, Daniels GA, Berking C, Jankovic V, Stankevich E, Booth J, Li S, Weinreich DM, Yancopoulos GD, Lowy I, Fury MG, Rischin D
- Issue date: 2020 Feb
- RF-Cemiplimab: First Drug Approved for the Treatment of Metastatic or Unresectable Cutaneous Squamous Cell Carcinoma.
- Authors: Morgado-Carrasco D, Bosch-Amate X, Fustà-Novell X, Giavedoni P
- Issue date: 2020 Mar
- Successful Administration of Cemiplimab to a Patient With Advanced Cutaneous Squamous Cell Carcinoma After Renal Transplantation.
- Authors: Ali SA, Arman HE, Patel AA, Birhiray RE
- Issue date: 2020 Mar
- Assessing the Value of Cemiplimab for Adults With Advanced Cutaneous Squamous Cell Carcinoma: A Cost-Effectiveness Analysis.
- Authors: Konidaris G, Paul E, Kuznik A, Keeping S, Chen CI, Sasane M, Xu Y, Atsou K, Ayers D, Ruiz ES, Khushalani NI, Cope S
- Issue date: 2021 Mar
- Radiation recall during cemiplimab therapy for locally advanced cutaneous squamous cell carcinoma.
- Authors: Vaccaro M, Bertino L, Santarpia M, Altavilla G, Cannavò SP
- Issue date: 2020 Nov